Medivir
Presence
Medivir is a company listed under the stock ticker MVIR (SE).
Executives
View the org chart displaying its 9 main executives
Most searched biographies at Medivir
Popular executive movements at Medivir
- Anette Lindqvist, Director, has left the company (posted on October 22 2023).
Create your alert
to follow the executive moves at Medivir.
Biotechnology
Medivir has 2,282 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by Medivir
- Medivir to present at Investing in Oncology Forum on April 10
- Medivir’s partner Vetbiolix announces positive results from Proof-of-Concept study with VBX-1000, previously known as MIV-701
- Medivir 2023 Annual Report published
- Notice of Annual General Meeting of Medivir AB (publ)
- Medivir to present at the Life Science Day in Gothenburg on March 6
- Medivir to present at Swiss Nordic Bio in Zürich on March 7
- Medivir presents data that strengthens the fostrox/Lenvima combination in primary liver cancer at EASL Liver Cancer Summit
- Change in Medivir's nomination committee before the 2024 AGM
- MEDIVIR AB – YEAR-END REPORT JANUARY – DECEMBER 2023
- Number of shares and votes in Medivir AB on 31 January 2024
- View more press releases Close
Social media about Medivir
- Medivir on Wikipedia, Google News & Yahoo Finance
- Medivir on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Jens Lindberg 
